Foundation Fighting Blindness Announces Leadership Changes
ncarol.com/10178661

Jason Menzo named chief executive officer

Russell Kelley, PhD, MBA, appointed managing director of the RD Fund

Ben Yerxa, PhD, to lead Opus Genetics, the first RD Fund- and Foundation-backed spin-off company

COLUMBIA, Md., June 21, 2022 /PRNewswire/ -- The Foundation Fighting Blindness, the world's leading organization committed to finding treatments and cures for blinding retinal diseases, announced today the promotions of Jason Menzo to chief executive officer (CEO) of the Foundation and Russell Kelley, PhD, MBA, to managing director of the Retinal Degeneration (RD) Fund, the venture arm of the Foundation, effective July 1, 2022. Ben Yerxa, PhD, who has served as CEO of the Foundation since 2017, will be transitioning to assume the permanent CEO position for Opus Genetics, the first spin-off company internally conceived and launched by the RD Fund to further the Foundation's mission.

More on ncarol.com

• IGH Naturals Announces Peer-Reviewed HuMOLYTE® Study Published in Frontiers in Nutrition
• Allstream Energy Partners Expands AI-Optimized Website Development Division to Meet Growing Demand in GEO / AEO Services
• America's Workforce Solution Named an OpenAI SMB Channel Partner, Bringing Enterprise-Grade AI to Main Street
• Data Tiles Introduces the Decision-Driven Enterprise to North America
• FitTrace Sync 1.11 Brings Apple Health and Google Health Connect Integration Into Its Mobile App

---

Show All News | Disclaimer | Report Violation